As GHRP-2 elevates the serum concentration of growth hormone (GH), it stimulates the release of somatostatin, also known as growth hormone inhibiting hormone (GHIH)
In theory, there is nothing against it since both share the same peptide foundation, but no data supports this approach
Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes
It felt impossible for me to do it before, this medication allowed it to feel possible. She has now lost more than 160 lbs in total and shares her story and lifestyle with more than 50,000 followers on TikTok
This article clarifies the relationship between fast food consumption and GLP-1 medication effectiveness, offering evidence-based guidance for optimal outcomes